beta-lactams has been researched along with lansoprazole in 1 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (lansoprazole) | Trials (lansoprazole) | Recent Studies (post-2010) (lansoprazole) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 2,281 | 803 | 600 |
Protein | Taxonomy | beta-lactams (IC50) | lansoprazole (IC50) |
---|---|---|---|
phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | 0.434 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.995 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 5.3148 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.3367 | |
WD repeat-containing protein 5 | Homo sapiens (human) | 5.9 | |
Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 5.9 | |
Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 8.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mitsuno, Y; Yoshida, H | 1 |
1 trial(s) available for beta-lactams and lansoprazole
Article | Year |
---|---|
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |